RIPK3 and metabolic dysfunction-associated steatotic liver disease: Moreover, studies have indicated that hepatic RIPK3 is closely associated with MASLD severity in both humans and mice and plays a critical role in managing liver metabolism, injury, inflammation, fibrosis, and carcinogenesis [17].